The ANKRD30B Knockout HeLa Polyclonal Cells comprise a CRISPR/Cas9-edited HeLa cell population in which the ANKRD30B gene has been disrupted. As a polyclonal product, this knockout pool preserves genetic heterogeneity while ensuring effective loss of target gene function. This model is designed for researchers seeking to interrogate ANKRD30B??s role without the clonal selection artifacts. The cells are provided as a ready-to-use population, suitable for various cell-based assays.
HeLa cells are a human epithelial line derived from a cervical adenocarcinoma and are HPV18-positive. The viral E6 and E7 oncoproteins inactivate p53 and pRb, creating a highly proliferative and genomically unstable background. This cell line is a standard model in cancer biology, known for its robust growth and suitability for techniques ranging from immunofluorescence to migration assays. Its adherent nature facilitates reproducible experimental setups.
The ANKRD30B gene codes for a protein containing ankyrin repeat domains, motifs that mediate protein-protein interactions. Classified as a cancer-testis antigen, its expression is normally restricted but can be aberrantly activated in tumors. The precise interactors, upstream regulators, and downstream targets of ANKRD30B remain undefined, making it a compelling subject for discovery. The knockout may compromise unknown protein networks, offering a tool to dissect these interactions.
In the HeLa context, loss of ANKRD30B allows investigation of how this putative scaffold protein affects cellular behavior in a cancer-relevant background. Researchers can assess whether its disruption alters proliferation, cell cycle progression, or motility, potentially linking ANKRD30B to oncogenic phenotypes. The HPV-altered environment may modulate any observed effects, providing deeper insight into tumor cell biology.
This knockout model is well-suited for functional genomics, cancer biology, and protein interaction studies. Standard assays include Western blotting, RT-qPCR, and immunofluorescence for expression analysis, as well as proliferation, cell cycle, and migration assays for functional readouts. These cells also support CRISPR validation and rescue experiments. For further details, contact Ascent Research.
